HQL
Tekla Life Sciences Investors
17.70$
+0.0%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q3 23 | Q4 23 | Q1 24 | Q3 24 | Q1 25 | Q3 25 | Q1 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 28.6% | – | 12.2% | – | 137.5% | 8.8% | 122.6% | 122.6% | 147.6% | 13.9% | 21.0% | 6.5% | |
| 71.4% | 100.0% | 87.8% | 100.0% | 100.0% | 91.2% | 100.0% | 100.0% | 100.0% | 86.1% | 79.0% | 93.5% | |
| 0.0% | 182.2% | 6.7% | 148.8% | 148.8% | 6.7% | 131.2% | 131.2% | 165.3% | 15.0% | 6.4% | 6.8% | |
| 0.4% | 1,887.4% | 68.9% | 1,652.0% | 148.8% | 130.0% | 131.6% | 131.6% | 166.2% | 345.7% | -1,062.8% | -42.4% | |
| -750.1% | -82.2% | -130.5% | -48.8% | -48.8% | -38.7% | -31.6% | -31.6% | -66.2% | -259.5% | 1,141.8% | 135.9% | |
| -750.1% | -1,787.5% | -130.5% | 1,752.1% | 1,752.1% | -38.7% | 2,433.4% | 2,433.4% | 1,830.0% | -259.5% | 1,141.8% | 135.9% | |
| 0.0% | -1,705,221.8% | -3.0% | 1,800,863.6% | 2.3% | -0.1% | 1,232.5% | -15.8% | – | – | – | – | |
| -750.1% | -1,787.5% | -130.5% | 1,752.1% | 1,752.1% | -38.7% | 2,433.4% | 2,433.4% | 1,830.0% | -259.5% | 1,141.8% | 135.9% | |
| -750.1% | -1,705.2% | -127.5% | 1,800.8% | 1,752.1% | -38.7% | 4,898.5% | 4,866.8% | 1,830.0% | -259.5% | 1,141.8% | 135.9% |
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.